These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21661104)

  • 21. Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit.
    Molokie RE; Montminy C; Dionisio C; Farooqui MA; Gowhari M; Yao Y; Suarez ML; Ezenwa MO; Schlaeger JM; Wang ZJ; Wilkie DJ
    Am J Emerg Med; 2018 Jan; 36(1):88-92. PubMed ID: 28802541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barriers to effective pain management in sickle cell disease.
    Wright K; Adeosum O
    Br J Nurs; 2009 Feb 12-25; 18(3):158-61. PubMed ID: 19223799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "I'm talking about pain": sickle cell disease patients with extremely high hospital use.
    Weisberg D; Balf-Soran G; Becker W; Brown SE; Sledge W
    J Hosp Med; 2013 Jan; 8(1):42-6. PubMed ID: 23169484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ketamine infusion for sickle cell pain crisis refractory to opioids: a case report and review of literature.
    Uprety D; Baber A; Foy M
    Ann Hematol; 2014 May; 93(5):769-71. PubMed ID: 24232306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pain management and quality of life in sickle cell disease.
    Howard J; Thomas VJ; Rawle HM
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):347-52. PubMed ID: 19670995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management.
    Tanabe P; Artz N; Mark Courtney D; Martinovich Z; Weiss KB; Zvirbulis E; Hafner JW
    Acad Emerg Med; 2010 Apr; 17(4):399-407. PubMed ID: 20370779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sickle cell anemia and pain: will data prevail over beliefs?
    Payne R
    Ann Emerg Med; 2009 May; 53(5):596-7. PubMed ID: 19380037
    [No Abstract]   [Full Text] [Related]  

  • 28. Morphine for the treatment of pain in sickle cell disease.
    Gupta M; Msambichaka L; Ballas SK; Gupta K
    ScientificWorldJournal; 2015; 2015():540154. PubMed ID: 25654130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid management and dependency among adult patients with sickle cell disease.
    Feliu MH; Wellington C; Crawford RD; Wood M; Edwards L; Byrd G; Edwards CL
    Hemoglobin; 2011; 35(5-6):485-94. PubMed ID: 21910605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study.
    Finkelstein Y; Schechter T; Garcia-Bournissen F; Kirby M; Nurmohamed L; Juurlink DN; Blanchette V; Koren G
    Clin Ther; 2007 Dec; 29(12):2738-43. PubMed ID: 18201591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease.
    Neri CM; Pestieau SR; Darbari DS
    Paediatr Anaesth; 2013 Aug; 23(8):684-9. PubMed ID: 23565738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.
    Raphael JL; Kamdar A; Beavers MB; Mahoney DH; Mueller BU
    Pediatr Blood Cancer; 2008 Jul; 51(1):82-5. PubMed ID: 18383165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse Models of Pain in Sickle Cell Disease.
    Sagi V; Song-Naba WL; Benson BA; Joshi SS; Gupta K
    Curr Protoc Neurosci; 2018 Oct; 85(1):e54. PubMed ID: 30265442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexmedetomidine ameliorates nocifensive behavior in humanized sickle cell mice.
    Calhoun G; Wang L; Almeida LE; Kenyon N; Afsar N; Nouraie M; Finkel JC; Quezado ZM
    Eur J Pharmacol; 2015 May; 754():125-33. PubMed ID: 25724786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.
    Puri L; Nottage KA; Hankins JS; Anghelescu DL
    Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and analgesic effects of methadone in children and adults with sickle cell disease.
    Horst J; Frei-Jones M; Deych E; Shannon W; Kharasch ED
    Pediatr Blood Cancer; 2016 Dec; 63(12):2123-2130. PubMed ID: 27572136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of acute painful crises in sickle cell disease.
    Kotila TR
    Clin Lab Haematol; 2005 Aug; 27(4):221-3. PubMed ID: 16048488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Headache and Facial Pain in Sickle Cell Disease.
    Vgontzas A; Charleston L; Robbins MS
    Curr Pain Headache Rep; 2016 Mar; 20(3):20. PubMed ID: 26879878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hospitalist perspective on opioid prescribing: A qualitative analysis.
    Calcaterra SL; Drabkin AD; Leslie SE; Doyle R; Koester S; Frank JW; Reich JA; Binswanger IA
    J Hosp Med; 2016 Aug; 11(8):536-42. PubMed ID: 27157317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.